FDA Calls for Loosening Eligibility in Noncurable Cancer Research
September 30, 2022
In an effort to broaden the eligibility criteria of noncurable cancer trials, the FDA has published final guidance recommending that sponsors and investigators allow patients who have not taken existing treatment options to participate.